Evidence map›Paper›PMID 26946493›Full record

ArticleProtein & cell2016

Loss of IκB kinase β promotes myofibroblast transformation and senescence through activation of the ROS-TGFβ autocrine loop.

Liang Chen, Zhimin Peng, Qinghang Meng, Maureen Mongan, Jingcai Wang, Maureen Sartor, Jing Chen, Liang Niu, Mario Medvedovic, Winston Kao and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Protein & cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. The TGFβ2-Snail1-miRNAClinical and translational medicine · 2024
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Vascular progenitor cell senescence in patients with Marfan syndrome.Journal of cellular and molecular medicine · 2019
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Liang ChenDepartment of Environmental Health and Center of Environmental Genetics, University of Cincinnati Medical Center, Cincinnati, OH, 45267, USA.
Zhimin PengDepartment of Environmental Health and Center of Environmental Genetics, University of Cincinnati Medical Center, Cincinnati, OH, 45267, USA.
Qinghang MengDepartment of Environmental Health and Center of Environmental Genetics, University of Cincinnati Medical Center, Cincinnati, OH, 45267, USA.
Maureen MonganDepartment of Environmental Health and Center of Environmental Genetics, University of Cincinnati Medical Center, Cincinnati, OH, 45267, USA.
Jingcai WangDepartment of Environmental Health and Center of Environmental Genetics, University of Cincinnati Medical Center, Cincinnati, OH, 45267, USA.
Maureen SartorDepartment of Environmental Health and Center of Environmental Genetics, University of Cincinnati Medical Center, Cincinnati, OH, 45267, USA.
Jing ChenDepartment of Environmental Health and Center of Environmental Genetics, University of Cincinnati Medical Center, Cincinnati, OH, 45267, USA.
Liang NiuDepartment of Environmental Health and Center of Environmental Genetics, University of Cincinnati Medical Center, Cincinnati, OH, 45267, USA.
Mario MedvedovicDepartment of Environmental Health and Center of Environmental Genetics, University of Cincinnati Medical Center, Cincinnati, OH, 45267, USA.
Winston KaoDepartment of Ophthalmology, University of Cincinnati Medical Center, Cincinnati, OH, 45267, USA.
Ying XiaDepartment of Environmental Health and Center of Environmental Genetics, University of Cincinnati Medical Center, Cincinnati, OH, 45267, USA. ying.xia@uc.edu.
University of Cincinnati · USUniversity of Cincinnati Medical Center · US

Funding

REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI YADAV, JAGJIT S · 1992 to 2022
$35.4M
The Role of MAP 3 Kinase 1 in Ocular Surface MorphogenesisR01EY015227 · NEI · UNIVERSITY OF CINCINNATI · PI XIA, YING · 2004 to 2019
$5.4M
NEI NIH HHS R01 EY015227NIEHS NIH HHS P30 ES006096
6 · The paper itself

Abstract

Using forward and reverse genetics and global gene expression analyses, we explored the crosstalk between the IκB kinase β (IKKβ) and the transforming growth factor β (TGFβ) signaling pathways. We show that in vitro ablation of Ikkβ in fibroblasts led to progressive ROS accumulation and TGFβ activation, and ultimately accelerated cell migration, fibroblast-myofibroblast transformation and senescence. Mechanistically, the basal IKKβ activity was required for anti-oxidant gene expression and redox homeostasis. Lacking this activity, IKKβ-null cells showed ROS accumulation and activation of stress-sensitive transcription factor AP-1/c-Jun. AP-1/c-Jun activation led to up-regulation of the Tgfβ2 promoter, which in turn further potentiated intracellular ROS through the induction of NADPH oxidase (NOX). These data suggest that by blocking the autocrine amplification of a ROS-TGFβ loop IKKβ plays a crucial role in the prevention of fibroblast-myofibroblast transformation and senescence.

Indexed as

Cellular SenescenceAdenoviridaeAnimalsAutocrine CommunicationCell LineCell MovementGenetic VectorsI-kappa B KinaseJNK Mitogen-Activated Protein KinasesMiceMyofibroblastsNADPH OxidasesOxidative StressPromoter Regions, GeneticReactive Oxygen SpeciesSignal TransductionI-kappa B KinaseJNK Mitogen-Activated Protein KinasesNADPH OxidasesReactive Oxygen SpeciesSuperoxide DismutaseSuperoxide Dismutase 2Transcription Factor AP-1Transforming Growth Factor betaIkB kinase β (IKKβ)myofibroblastnuclear factor κB (NF-κB)reactive oxygen species (ROS)senescencetransforming growth factors β (TGFβ)

Identifiers

PMID26946493
PMCPMC4853320
OpenAlexW2295560504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.